Medical stocks don't generally have high dividends, but Abbvie (NYSE: ABBV), Pfizer (NYSE: PFE), and Gilead Sciences (NASDAQ: GILD) all have dividends with yields of 3.5% or more, and these pharmaceuticals stocks serve as a great hedge against inflation because their business models are largely resistant to recessions. In the meantime, AbbVie has a huge pipeline that includes therapies in immunology, oncology, neuroscience, virology, women's health, and gastroenterology, along with Allergan's aesthetics drugs. On Oct. 11, the FDA accepted for priority review the supplemental Biologics License Application (sBLA) for Trodelvy to treat a late-stage of HR+/HER2- metastatic breast cancer.